# Spero Therapeutics, Inc.: Form DEF 14A, filed Apr 27, 2018

- Company: [Spero Therapeutics, Inc.](/companies/spro.md) (CIK 1701108)
- Form: DEF 14A
- Filed: 2018-04-27
- Accepted by EDGAR: Apr 27, 2018, 08:20 ET
- Period: 2018-06-05
- Accession: 0001193125-18-136751
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1701108/000119312518136751/d494847ddef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1701108/000119312518136751/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1701108/000119312518136751/d494847ddef14a.htm

Filed Apr 27, 2018.
Source: SEC EDGAR, the filing index for accession 0001193125-18-136751. Last ingested by Listed: Nov 13, 2026, 16:27 ET. No prices; not investment advice.
